Contribution: Industrial Research Assistance Program – Contributions to Firms
Realize Medical Inc.
$328,580.00
AI-Based Planning of Transarterial Radioembolization (TARE)
FY 2025-26 · 2025-06-02
Summary
This project aims at creating an AI-powered software system for planning transarterial radioembolization (TARE) treatments of liver tumors. The system will automatically segment liver tissue, tumors, and vascular structures from medical images routinely acquired by interventional radiologists. Building on our existing Elucis platform and previous IRAP-funded AI capabilities, the system will aid in the calculation of metrics critical to the TARE treatment workflow.
Department
Program
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)
Recipient
Location
Ottawa|Ottawa, Ontario, Canada
Recipient Type
For-profit organization
Business Number
718021710
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
As published
Agreement End Date
2026-05-31
Agreement Number
1034140
Agreement Start Date
2025-06-02
Agreement Title
AI-Based Planning of Transarterial Radioembolization (TARE)
Agreement Title (French)
Planification de la radioembolisation transartérielle (TARE) basée sur l’IA
Agreement Type
Contribution
Agreement Value
$328,580.00
Amendment Number
0
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
This project aims at creating an AI-powered software system for planning transarterial radioembolization (TARE) treatments of liver tumors. The system will automatically segment liver tissue, tumors, and vascular structures from medical images routinely acquired by interventional radiologists. Building on our existing Elucis platform and previous IRAP-funded AI capabilities, the system will aid in the calculation of metrics critical to the TARE treatment workflow.
Description (French)
Ce projet vise à créer un système logiciel alimenté par l’IA pour planifier les traitements de radioembolisation transartérielle (TARE) des tumeurs du foie. Le système segmentera automatiquement le tissu hépatique, les tumeurs et les structures vasculaires à partir d’images médicales acquises régulièrement par les radiologues interventionnels. S’appuyant sur notre plateforme Elucis existante et sur les capacités d’IA précédemment financées par le PARI, le système aidera au calcul des métriques essentielles au flux de travail du traitement TARE.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Ottawa Centre
Federal Riding (French)
Ottawa-Centre
Federal Riding Number
35075
NAICS Code
511211
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
718021710
Recipient City
Ottawa|Ottawa
Recipient Country
CA
Recipient Legal Name
Realize Medical Inc.
Recipient Postal Code
K1Y 2C5
Recipient Province or Territory
ON
Recipient Type
F
Reference Number
172-2025-2026-Q2-1034140
